TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11985388

Group type: EXPERIMENTAL
Intervention: Acetazolamide 500 mg daily
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 10330635

Group type: EXPERIMENTAL
Intervention: Lidocaine 2% jelly applied once on arrival at the surgicenter
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Lidocaine 2% jelly applied on arrival and about 5 minutes prior to surgery
Number of subjects: 180

Group type: COMPARATOR
Intervention: Topical eyedrop anesthesia
Number of subjects: 180

Group type: COMPARATOR
Intervention: Intracameral lidocaine
Number of subjects: 180
Study: 8545141

Group type: EXPERIMENTAL
Intervention: Capsaicin cream (0.075%) applied 4 times a day
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (methyl nicotinate) applied 4 times a day
Number of subjects: 40
Study: 1901528

Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg b.i.d.
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Captopril 25 mg t.i.d.
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 6280052

Group type: EXPERIMENTAL
Intervention: Topical acyclovir
Number of subjects: 188

Group type: COMPARATOR
Intervention: Placebo (polyethylene glycol ointment)
Number of subjects: 188
Study: 31717948

Group type: EXPERIMENTAL
Intervention: Micronutrient powder supplementation for up to 3 months
Number of subjects: 224
Study: 29231321

Group type: EXPERIMENTAL
Intervention: Acupuncture-moxibustion periodic therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional acupuncture-moxibustion therapy
Number of subjects: 60
Study: 26212400

Group type: EXPERIMENTAL
Intervention: Rehabilitation Intensity of Therapy Scale
Number of subjects: 1946

Group type: EXPERIMENTAL
Intervention: Linear mixed‐effects modeling
Number of subjects: 1946
Study: 22371090

Group type: EXPERIMENTAL
Intervention: Formaldehyde exposure at 0.7 ppm for 4 hours
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Formaldehyde exposure at 0.4 ppm for 4 hours with peaks of 0.8 ppm for 15 minutes
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Subjective complaints regarding olfactory symptoms
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control condition (0 ppm)
Number of subjects: 41
Study: 20947648

Group type: EXPERIMENTAL
Intervention: 100% oxygen
Number of subjects: 24

Group type: COMPARATOR
Intervention: room air
Number of subjects: 24
Study: 19060263

Group type: EXPERIMENTAL
Intervention: Initial medicine or surgery
Number of subjects: 607

Group type: EXPERIMENTAL
Intervention: Drivers with moderate/severe bilateral visual field loss (VFL)
Number of subjects: 607

Group type: EXPERIMENTAL
Intervention: Drivers who remained drivers over follow-up
Number of subjects: 607
Study: 16856702

Group type: EXPERIMENTAL
Intervention: Vibration board training (25 hertz, 10 repetitions lasting 1 minute each, for 2 weeks)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group training (10 daily sessions for 2 weeks, 3 series of 10 repetitions of flexi‐extension of the foot against an elastic band)
Number of subjects: 16
Study: 12883361

Group type: COMPARATOR
Intervention: 5‐S‐Cysteinyldopa (5‐S‐CD)
Number of subjects: 152

Group type: COMPARATOR
Intervention: 4‐Amino‐3‐hydroxyphenylalanine (4‐AHP)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Correlation of serum levels
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Serum 4‐AHP levels
Number of subjects: 152
Study: 10834891

Group type: EXPERIMENTAL
Intervention: Picolax
Number of subjects: 1442

Group type: COMPARATOR
Intervention: Phosphate enema
Number of subjects: 1442
Study: 9337827

Group type: EXPERIMENTAL
Intervention: Non-invasive assist-control ventilation (ACV)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Spontaneous breathing (SB)
Number of subjects: 15
Study: 7692410

Group type: EXPERIMENTAL
Intervention: Medtronic 6500
Number of subjects: 35

Group type: COMPARATOR
Intervention: Braided multifilament temporary pacing leads
Number of subjects: 35
Study: 3754433

Group type: EXPERIMENTAL
Intervention: Knee brace worn for 6 weeks
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (no brace)
Number of subjects: 17
Study: 30711651

Group type: EXPERIMENTAL
Intervention: Accelerated vaccination schedule (0, 7, and 21 days)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Routine vaccination schedule (0, 1, and 6 months)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Accelerated vaccination schedule
Number of subjects: 126

Group type: COMPARATOR
Intervention: Routine vaccination schedule
Number of subjects: 126
Study: 28352939

Group type: EXPERIMENTAL
Intervention: Individualized physiotherapy and shoulder taping
Number of subjects: 140

Group type: COMPARATOR
Intervention: Individualized physiotherapy only
Number of subjects: 140
Study: 26537897

Group type: EXPERIMENTAL
Intervention: Extensively hydrolyzed milk protein formula (100% whey protein)
Number of subjects: 370

Group type: COMPARATOR
Intervention: Preterm children's formula
Number of subjects: 370
Study: 23384977

Group type: EXPERIMENTAL
Intervention: Active encouragement for diagnostics and treatment after screening
Number of subjects: 0

Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 0
Study: 21340599

Group type: EXPERIMENTAL
Intervention: Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS) total scale
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS) Obsessions subscale
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS) Compulsions subscale
Number of subjects: 42
Study: 19403719

Group type: EXPERIMENTAL
Intervention: Plant stanol drink (2.0 g/d)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Simvastatin (10 mg)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Simvastatin + Plant stanol drink
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 17850382

Group type: EXPERIMENTAL
Intervention: Montelukast 10 mg daily
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 15459610

Group type: EXPERIMENTAL
Intervention: Nicorandil (4 mg as a bolus injection followed by constant infusion at 8 mg/hour for 24 hours)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Nicorandil
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control
Number of subjects: 58
Study: 11271456

Group type: EXPERIMENTAL
Intervention: Excimer laser trephination (193‐nm Meditec MEL60)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Motor trephination with the Mikrokeratron
Number of subjects: 179
Study: 9749683

Group type: EXPERIMENTAL
Intervention: TENS (110Hz, 200microsec)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study: 8147334

Group type: EXPERIMENTAL
Intervention: 20 mg beta-carotene (BC) daily for 4 weeks in smokers
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo in smokers
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 20 mg beta-carotene (BC) daily for 4 weeks in nonsmokers
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo in nonsmokers
Number of subjects: 70
Study: 3169754

Group type: EXPERIMENTAL
Intervention: Pivampicillin (700 mg twice a day for 7 days)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Erythromycin (500 mg twice a day for 7 days)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Pivampicillin
Number of subjects: 49

Group type: COMPARATOR
Intervention: Erythromycin
Number of subjects: 49
Study: 30063168

Group type: EXPERIMENTAL
Intervention: Native whey protein
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Micellar casein
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Whey-casein blend
Number of subjects: 0
Study: 28677416

Group type: EXPERIMENTAL
Intervention: Manual closed-loop delivery using SP-MPC algorithm
Number of subjects: 10

Group type: COMPARATOR
Intervention: Open-loop using sensor-augmented pump therapy (open-loop SAP)
Number of subjects: 10
Study: 26305992

Group type: EXPERIMENTAL
Intervention: Multidisciplinary coordinated intervention by advanced practice nurses
Number of subjects: 146

Group type: COMPARATOR
Intervention: Enhanced usual care
Number of subjects: 146
Study: 23374815

Group type: EXPERIMENTAL
Intervention: Thulium laser transurethral enucleation of the prostate (ThuLEP)
Number of subjects: 158

Group type: COMPARATOR
Intervention: Plasmakinetic bipolar resection of the prostate (PKRP)
Number of subjects: 158
Study: 21505541

Group type: EXPERIMENTAL
Intervention: Clear corneal tunnel incision (Group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sclero-corneal tunnel incision (Group B)
Number of subjects: 60
Study: 19471134

Group type: EXPERIMENTAL
Intervention: Comorbid psychiatric disorders (PD)
Number of subjects: 143
Study: 17934380

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 10
Study: 15525863

Group type: EXPERIMENTAL
Intervention: Education by pamphlets
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Education by lecture and flash cards
Number of subjects: 129

Group type: COMPARATOR
Intervention: Control group (not manipulated)
Number of subjects: 129
Study: 12644414

Group type: EXPERIMENTAL
Intervention: Lactate in the prime solution
Number of subjects: 20

Group type: COMPARATOR
Intervention: Lactate free prime solution
Number of subjects: 20
Study: 10363944

Group type: EXPERIMENTAL
Intervention: Long SOA (3.5 s)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Intermediate SSA and SDA manipulations
Number of subjects: 14
Study: 7593107

Group type: EXPERIMENTAL
Intervention: Bupivacaine femoral nerve block
Number of subjects: 50

Group type: COMPARATOR
Intervention: Systemic analgesia alone
Number of subjects: 50
Study: 2266221

Group type: EXPERIMENTAL
Intervention: Individually self-administered video-tape modeling treatment (IVM)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: IVM treatment plus therapist consultation (IVMC)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Waiting-list control group (CON)
Number of subjects: 43
Study: 7393376

Group type: EXPERIMENTAL
Intervention: Nondialyzed uremic patients
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Dialyzed uremic patients
Number of subjects: 85

Group type: COMPARATOR
Intervention: Healthy volunteers and patients with normal renal functions
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Younger uremic patients (under 55 years)
Number of subjects: 85
Study: 30636466

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Brief panic-focused psychodynamic psychotherapy
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: PDSS
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: PDSS-SR
Number of subjects: 221
Study: 29578592

Group type: EXPERIMENTAL
Intervention: Cancer prevention seminar
Number of subjects: 395

Group type: COMPARATOR
Intervention: Biospecimen education seminar
Number of subjects: 395
Study: 26156073

Group type: EXPERIMENTAL
Intervention: Everolimus (10 mg once daily, titrated based on tolerability)
Number of subjects: 112
Study: 24447434

Group type: EXPERIMENTAL
Intervention: Adjuvant tamoxifen (1-3 years)
Number of subjects: 563

Group type: COMPARATOR
Intervention: No systemic treatment (observation)
Number of subjects: 563
Study: 23145755

Group type: EXPERIMENTAL
Intervention: Bupivacaine 15 mg 0.5% (group 1)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Levobupivacaine 15 mg 0.5% (group 2)
Number of subjects: 44
Study: 21146662

Group type: EXPERIMENTAL
Intervention: PPCI with ischemic postconditioning (IPost)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Conventional PPCI
Number of subjects: 118
Study: 17431208

Group type: EXPERIMENTAL
Intervention: Mild intraoperative hypothermia (33 degrees C)
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Normothermic treatment
Number of subjects: 185

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 185
Study: 15530581

Group type: EXPERIMENTAL
Intervention: Website condition (participants received four stage-targeted e-mails over 8 weeks)
Number of subjects: 327
Study: 12355569

Group type: EXPERIMENTAL
Intervention: Dynamic cooling device (DCD) with cryogen spurt duration of 20 milliseconds
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Dynamic cooling device (DCD) with longer spurt durations (40, 60, 80, 100 milliseconds)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Dynamic cooling device (DCD) with spurt durations of 20-60 milliseconds
Number of subjects: 10

Group type: COMPARATOR
Intervention: Higher fluences without cooling
Number of subjects: 10
Study: 10211629

Group type: EXPERIMENTAL
Intervention: Cardiac troponin T (cTnT)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Cardiac troponin I (cTnI)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Follow-up over 18 months
Number of subjects: 49
Study: 8556024

Group type: EXPERIMENTAL
Intervention: Appetizer condition (ingestion of pudding before Stroop task)
Number of subjects: 51

Group type: COMPARATOR
Intervention: No-appetizer condition
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Stroop task with food words
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Stroop task with body shape words
Number of subjects: 51
Study: 29643159

Group type: EXPERIMENTAL
Intervention: Multivitamin supplements containing 150 µg iodine
Number of subjects: 1275
Study: 27183079

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) used to cover the autogenous palatal bone block
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (only autogenous palatal bone block without PRF)
Number of subjects: 12
Study: 25528742

Group type: EXPERIMENTAL
Intervention: Dynamic Axial Fixator (DAF)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Locked Compression Plate (LCP)
Number of subjects: 20
Study: 23746688

Group type: EXPERIMENTAL
Intervention: Protocol A: 80 mL iopromide 370/4 mL/sec = IDR 1.4 gI/sec
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Protocol B: 80 mL iopromide 370 at 3 mL/sec = IDR 1.1 gI/sec
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Protocol C: 98 mL iopromide 300 at 4.9 mL/sec = IDR 1.4 gI/sec
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Protocol D: 98 mL iopromide 300 at 3.7 mL/sec = IDR 1.1 gI/sec
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Protocol A
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Protocols A and B
Number of subjects: 120
Study: 21432621

Group type: EXPERIMENTAL
Intervention: Generic tamsulosin sustained-release tablets (Prostam(®))
Number of subjects: 24
Study: 19092351

Group type: EXPERIMENTAL
Intervention: 8 mg dexamethasone
Number of subjects: 72
Study: 16871060

Group type: EXPERIMENTAL
Intervention: Remifentanil (0-15 ng/ml) and sevoflurane (0-6 vol%)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Combination of 0.75 vol% sevoflurane and 6.2 ng/ml remifentanil
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Remifentanil and sevoflurane
Number of subjects: 16
Study: 14680725

Group type: EXPERIMENTAL
Intervention: 40 mg/day quinapril for 8 weeks
Number of subjects: 336

Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 336
Study: 10870853

Group type: EXPERIMENTAL
Intervention: 60 mcg PGE1 daily given IV in 250 mL saline over a period of 2 hours (21 patients)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo (250 mL saline, 21 patients)
Number of subjects: 42
Study: 9109265

Group type: EXPERIMENTAL
Intervention: PLA/PGA membranes
Number of subjects: 9

Group type: COMPARATOR
Intervention: e‐PTFE membranes
Number of subjects: 9
Study: 8473092

Group type: EXPERIMENTAL
Intervention: New technique (Group I)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: New technique after failures (Group III)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Traditional technique (Group II)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: New technique reattempted after failures (Group IV)
Number of subjects: 80
Study: 3700954

Group type: EXPERIMENTAL
Intervention: Protective sports eyewear (seven different types); specific dosages and durations not mentioned.
Number of subjects: 0
Study: 29722837

Group type: EXPERIMENTAL
Intervention: Fortified mother's milk
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Unfortified mother's milk
Number of subjects: 239

Group type: COMPARATOR
Intervention: Preterm formula
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Early rapid growth (crossing of weight percentiles with >1 SD)
Number of subjects: 239
Study: 27993223

Group type: EXPERIMENTAL
Intervention: Therapist-guided internet-based CBT (BiP OCD)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Waitlist condition
Number of subjects: 67
Study: 25038064

Group type: EXPERIMENTAL
Intervention: MIRT Group (two 28-day multidisciplinary intensive rehabilitation treatments at 1-year interval)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control Group (only drug)
Number of subjects: 40
Study: 24510077

Group type: EXPERIMENTAL
Intervention: Femtosecond laser Femto LDV(TM) Ziemer
Number of subjects: 32

Group type: COMPARATOR
Intervention: Microkeratome Hansatome (TM) Bausch & Lomb
Number of subjects: 32
Study: 20962323

Group type: EXPERIMENTAL
Intervention: t(14;16) positive patients
Number of subjects: 1003

Group type: COMPARATOR
Intervention: t(14;16) negative patients
Number of subjects: 1003
Study: 18497611

Group type: EXPERIMENTAL
Intervention: Epidural analgesia
Number of subjects: 12

Group type: COMPARATOR
Intervention: Patient-controlled analgesia with intravenous morphine
Number of subjects: 12
Study: 17361522

Group type: EXPERIMENTAL
Intervention: Compound Glycyrrhizin Injection (CGI)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 42
Study: 12553391

Group type: EXPERIMENTAL
Intervention: LMA‐ProSeal laryngeal mask airway
Number of subjects: 30

Group type: COMPARATOR
Intervention: Classic laryngeal mask airway
Number of subjects: 30
Study: 11712434

Group type: EXPERIMENTAL
Intervention: Embolization
Number of subjects: 50
Study: 8805994

Group type: EXPERIMENTAL
Intervention: Calcitriol, 1 microgram twice daily
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Calcitriol, 0.5 microgram twice daily
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo twice daily
Number of subjects: 36
Study: 1621796

Group type: EXPERIMENTAL
Intervention: Materials-based occupation
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Imagery-based occupation
Number of subjects: 15

Group type: COMPARATOR
Intervention: Rote exercise
Number of subjects: 15
Study: 6230929

Group type: EXPERIMENTAL
Intervention: Chlorozotocin
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Neocarzinostatin
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: MeCCNU
Number of subjects: 122
Study: 29656823

Group type: EXPERIMENTAL
Intervention: Association Splitting (AS)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Cognitive Remediation (CR)
Number of subjects: 109
Study: 27072798

Group type: EXPERIMENTAL
Intervention: Retro walking
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Forward walking
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 69
Study: 26277872

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (loading dose of 1.0 μg/kg infused over 10 minutes, maintenance dose of 0.4 μg/kg per hour for 6 hours)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Normoalbuminemia (control group)
Number of subjects: 30
Study: 23912692

Group type: COMPARATOR
Intervention: Gemcitabine alone (1,000 mg m(‐2))
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Gemcitabine plus cisplatin (G + C) (1,000 mg m(‐2) gemcitabine and 25 mg m(‐2) cisplatin)
Number of subjects: 46
Study: 20206795

Group type: COMPARATOR
Intervention: Ticlopidine 250 mg alone
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ticlopidine 250 mg with Ginkgo biloba extract 80 mg
Number of subjects: 24
Study: 19115636

Group type: EXPERIMENTAL
Intervention: 20% protein‐free calf blood extract eye drops
Number of subjects: 240

Group type: COMPARATOR
Intervention: 5000 IU/ml recombinant human epidermal growth factor (rhEGF) eye drops
Number of subjects: 240
Study: 16570352

Group type: EXPERIMENTAL
Intervention: Sumatriptan
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 14740127

Group type: EXPERIMENTAL
Intervention: Graduated compression stockings (GCS) alone
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Graduated compression stockings (GCS) in combination with heparin
Number of subjects: 39

Group type: COMPARATOR
Intervention: Graduated compression stockings (GCS)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Nontreatment or other antithrombotic methods
Number of subjects: 39
Study: 11369627

Group type: EXPERIMENTAL
Intervention: Filgrastim-mobilized blood stem cell transplantation
Number of subjects: 115

Group type: COMPARATOR
Intervention: Allogeneic marrow transplantation
Number of subjects: 115
Study: 9408714

Group type: EXPERIMENTAL
Intervention: Active community-level intervention
Number of subjects: 22

Group type: COMPARATOR
Intervention: Comparison
Number of subjects: 22
Study: 7708953

Group type: EXPERIMENTAL
Intervention: Radiotherapy for early breast cancer
Number of subjects: 559

Group type: EXPERIMENTAL
Intervention: Radiation dose distributions assessment in a separate group of 37 women
Number of subjects: 559
Study: 3371023

Group type: EXPERIMENTAL
Intervention: 1.5 mg/kg iv every 6 h
Number of subjects: 40

Group type: COMPARATOR
Intervention: 0.75 mg/kg iv every 6 h
Number of subjects: 40

Group type: COMPARATOR
Intervention: 2 mg/kg by NG tube every 12 h
Number of subjects: 40

Group type: COMPARATOR
Intervention: 4 mg/kg by NG tube every 12 h
Number of subjects: 40
Study: 31941546

Group type: EXPERIMENTAL
Intervention: 7 days of antibiotic treatment
Number of subjects: 134

Group type: COMPARATOR
Intervention: 14 days of antibiotic treatment
Number of subjects: 134
Study: 30063766

Group type: COMPARATOR
Intervention: Leicester MII protocol in controls
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Leicester MII protocol in fever patients
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Leicester MII protocol in sepsis patients
Number of subjects: 56
Study: 26234917

Group type: EXPERIMENTAL
Intervention: Preoperative assessment using MDVP
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Postoperative assessment using MDVP
Number of subjects: 121
Study: 24982504

Group type: EXPERIMENTAL
Intervention: Tacrolimus/sirolimus (Tac/Sir)
Number of subjects: 304

Group type: COMPARATOR
Intervention: Tacrolimus/methotrexate (Tac/Mtx)
Number of subjects: 304